WILSONVILLE, Ore., March 21, 2019 /PRNewswire-PRWeb/ -- RevMedx, Inc., a global leader in innovative devices that control
XGAUZE is standard issue in selected US Armed Forces medical kits and has several hundred documented treatments since its release in 2015. Using expanding sponge technology similar to RevMedx's XSTAT injectable device, compressed sponges embedded in XGAUZE rapidly absorb blood and expand to ten times their original size. One expanded XGAUZE fills about the same volume as three standard gauze dressings. XGAUZE may provide significant advantages for wound-packing and treatment of certain types of traumatic injuries seen in pre-hospital settings.
Andrew Barofsky, President and CEO of RevMedx, Inc., stated, "CE Mark on our XGAUZE product now makes our entire portfolio available to emergency responders and surgeons in the European Union and around the world. This certification clearly indicates that XGAUZE and our supporting quality system have met the essential requirements for product safety, performance and usability, in compliance with rigorous requirements set by the EU's Medical Device Directive (MDD)."
For victims of violence or accidents, early control of severe bleeding may prevent shock and may be life-saving. The United States Army Institute of Surgical Research reports that 30 to 40 percent of civilian deaths by traumatic injury are the result of hemorrhaging; of those deaths, 33 to 56 percent occur before the patient reaches an emergency care facility.
About RevMedx Based in Wilsonville, Oregon, RevMedx is a privately held medical device company whose goal is to design, develop, and manufacture innovative medical products that save lives. Our product line includes XSTAT, XGAUZE, AIRWRAP, PARABELT, SHARKBITE Blast Injury Kits, and TX Series Ratcheting Tourniquets. Additional information about RevMedx and our products can be found at http://www.revmedx.com.
Media Contact: Will Fox VP Sales & Marketing Phone: (503) 218-2172 Email: email@example.com
Subscribe to our Free Newsletters!